| Title : Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease - Casademont_2003_J.Neurol.Sci_206_23 |
| Author(s) : Casademont J , Miro O , Rodriguez-Santiago B , Viedma P , Blesa R , Cardellach F |
| Ref : Journal of Neurology Sci , 206 :23 , 2003 |
|
Abstract :
Electron transport chain (ETC) dysfunction has been claimed to contribute to the expression of neurodegenerative disorders. We have investigated the effects of the treatment with rivastigmine, a commonly used cholinesterase inhibitor, on lymphocyte mitochondria of patients with Alzheimer's disease (AD). Increased enzymatic activities of diverse complexes and oxidative capacity of the ETC were found. Enhanced mitochondrial ETC function may contribute to the beneficial effects of rivastigmine on clinical manifestations of AD. |
| PubMedSearch : Casademont_2003_J.Neurol.Sci_206_23 |
| PubMedID: 12480080 |
Casademont J, Miro O, Rodriguez-Santiago B, Viedma P, Blesa R, Cardellach F (2003)
Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease
Journal of Neurology Sci
206 :23
Casademont J, Miro O, Rodriguez-Santiago B, Viedma P, Blesa R, Cardellach F (2003)
Journal of Neurology Sci
206 :23